Monash Ivf Group Ltd (MVF) - Cash Flow Conversion Efficiency

Latest as of June 2026: 0.067x

Based on the latest financial reports, Monash Ivf Group Ltd (MVF) has a cash flow conversion efficiency ratio of 0.067x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$17.07 Million ≈ $12.08 Million USD) by net assets (AU$253.47 Million ≈ $179.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Monash Ivf Group Ltd market capitalisation for the company's overall valuation and market capitalisation.

Monash Ivf Group Ltd - Cash Flow Conversion Efficiency Trend (2013–2026)

This chart illustrates how Monash Ivf Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Monash Ivf Group Ltd (MVF) stock price for real-time trading data and today's change.

Monash Ivf Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Monash Ivf Group Ltd ranked by their cash flow conversion efficiency. Review Monash Ivf Group Ltd (MVF) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Firstec KO:010820	0.003x
BF Utilities Limited NSE:BFUTILITIE	0.229x
Chicago Atlantic BDC, Inc. NASDAQ:LIEN	0.000x
Pyrophyte Acquisition Corp. II NYSE:PAII	-0.002x
TERACT EO 1 F:6O8	N/A
Vef AB ST:VEFAB	-0.001x
Vendome Acquisition Corporation I Class A Ordinary Shares NASDAQ:VNME	-0.566x
Nampak JSE:NPK	0.429x

Annual Cash Flow Conversion Efficiency for Monash Ivf Group Ltd (2013–2026)

The table below shows the annual cash flow conversion efficiency of Monash Ivf Group Ltd from 2013 to 2026. Also see MVF asset base for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-06-30	AU$253.47 Million ≈ $179.35 Million	AU$30.20 Million ≈ $21.37 Million	0.119x	+131.29%
2025-06-30	AU$250.42 Million ≈ $177.19 Million	AU$12.90 Million ≈ $9.13 Million	0.052x	-75.80%
2024-06-30	AU$246.66 Million ≈ $174.53 Million	AU$52.52 Million ≈ $37.16 Million	0.213x	+49.71%
2023-06-30	AU$275.07 Million ≈ $194.63 Million	AU$39.12 Million ≈ $27.68 Million	0.142x	+20.37%
2022-06-30	AU$269.89 Million ≈ $190.97 Million	AU$31.89 Million ≈ $22.56 Million	0.118x	-27.88%
2021-06-30	AU$268.44 Million ≈ $189.94 Million	AU$43.98 Million ≈ $31.12 Million	0.164x	+32.90%
2020-06-30	AU$252.12 Million ≈ $178.39 Million	AU$31.08 Million ≈ $21.99 Million	0.123x	-35.40%
2019-06-30	AU$173.43 Million ≈ $122.72 Million	AU$33.09 Million ≈ $23.42 Million	0.191x	+22.79%
2018-06-30	AU$166.86 Million ≈ $118.06 Million	AU$25.93 Million ≈ $18.35 Million	0.155x	-1.92%
2017-06-30	AU$163.52 Million ≈ $115.70 Million	AU$25.91 Million ≈ $18.33 Million	0.158x	-44.43%
2016-06-30	AU$154.88 Million ≈ $109.58 Million	AU$44.16 Million ≈ $31.25 Million	0.285x	+14.05%
2015-06-30	AU$144.03 Million ≈ $101.91 Million	AU$36.01 Million ≈ $25.48 Million	0.250x	-13.85%
2014-06-30	AU$124.82 Million ≈ $88.32 Million	AU$36.22 Million ≈ $25.63 Million	0.290x	+145.23%
2013-06-30	AU$-46.92 Million ≈ $-33.20 Million	AU$30.11 Million ≈ $21.30 Million	-0.642x	--

About Monash Ivf Group Ltd

AU:MVF Australia Diagnostics & Research

Market Cap

$206.77 Million

AU$292.23 Million AUD

Market Cap Rank

#16475 Global

#459 in Australia

Share Price

AU$0.75

Change (1 day)

+0.00%

52-Week Range

AU$0.59 - AU$0.88

All Time High

AU$1.65